Could a steroid injection double as a painkiller for brain surgery?
NCT ID NCT07788261
First seen Aug 26, 2026 · Last updated Aug 27, 2026 · Updated 1 time
Summary
This trial asks whether adding a steroid called dexamethasone to a local anesthetic (lidocaine) can improve pain relief after brain surgery (craniotomy). About 100 adults scheduled for this surgery will receive either the steroid-anesthetic mix or the standard anesthetic with epinephrine, injected into the scalp before the incision. Researchers will measure pain scores, opioid use, and vital signs to see if the combination offers better, longer-lasting pain control.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A combination of dexamethasone (a steroid) and lidocaine (a local anesthetic) injected into the scalp before surgery
- What this could lead to
- If it works, this could point toward a better way to manage pain after brain surgery, potentially reducing the need for opioids.
- What could go wrong
- This is a small, early-stage trial, and the benefit may be modest or not appear at all. There are also risks like infection or allergic reactions, though rare.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
100 people
The number who actually took part.
- Started
-
Dec 2024
- Finished
-
Feb 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients age between 20 and 60 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I and II * Scheduled for elective supratentorial tumor craniotomy under general anesthesia. Exclusion Criteria: * Patients with known hypersensitivity to lidocaine or dexamethasone. * Chronic corticosteroid therapy. * Pre-existing coagulopathy. * Significant hepatic or renal impairment.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Craniotomy are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University
Asyut, Asyut Governorate, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a steroid outperform a standard antiemetic to stop Post-Surgery sickness?
- Can a simple wash of local anesthetic cut Post-Surgery pain and opioid use?
- Can a new patch safely protect the brain after surgery?
- A steroid-sparing strategy: could olanzapine curb chemo nausea without the metabolic toll?
- Can a simple infusion make sinus surgery safer and clearer?
- Drug combo may cut opioid use after lung surgery